These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 26669276)
1. Epigenetic targets for the treatment of neurodegenerative diseases. Peedicayil J Clin Pharmacol Ther; 2016 May; 99(5):481. PubMed ID: 26669276 [No Abstract] [Full Text] [Related]
2. Promising Targets for the Treatment of Neurodegenerative Diseases. Budd Haeberlein SL; Harris TJ Clin Pharmacol Ther; 2015 Nov; 98(5):492-501. PubMed ID: 26250447 [TBL] [Abstract][Full Text] [Related]
3. [Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments]. Jochims C; Mazitschek U; Jäger D; Goldschmidt H Internist (Berl); 2006 Jun; 47(6):633-41. PubMed ID: 16767478 [TBL] [Abstract][Full Text] [Related]
4. The promise of targeted therapy: cancer drugs become more specific. Segota E; Bukowski RM Cleve Clin J Med; 2004 Jul; 71(7):551-60. PubMed ID: 15320364 [TBL] [Abstract][Full Text] [Related]
5. Prospects for gene therapy in inherited neurodegenerative diseases. Cardone M Curr Opin Neurol; 2007 Apr; 20(2):151-8. PubMed ID: 17351484 [TBL] [Abstract][Full Text] [Related]
6. Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future. Piguet F; Alves S; Cartier N Hum Gene Ther; 2017 Nov; 28(11):988-1003. PubMed ID: 29035118 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer into the central and peripheral nervous system: applications for the treatment of neurodegenerative diseases and peripheral neuropathies. Pradat PF; Mallet J Biotechnol Genet Eng Rev; 2003; 20():49-76. PubMed ID: 14997846 [No Abstract] [Full Text] [Related]
8. Targeted gene repair and its application to neurodegenerative disorders. Parekh-Olmedo H; Krainc D; Kmiec EB Neuron; 2002 Feb; 33(4):495-8. PubMed ID: 11856524 [TBL] [Abstract][Full Text] [Related]
9. The ons and offs of inducible transgenic technology: a review. Yamamoto A; Hen R; Dauer WT Neurobiol Dis; 2001 Dec; 8(6):923-32. PubMed ID: 11741388 [TBL] [Abstract][Full Text] [Related]
10. Hot topic: updates on therapeutic approaches to inflammatory skin diseases: from molecular targets to drug development. Part I. Korkina L; Pastore S Curr Drug Metab; 2010 Mar; 11(3):208-9. PubMed ID: 20443778 [No Abstract] [Full Text] [Related]
11. The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy. Zhang CC; Xing A; Tan MS; Tan L; Yu JT Mol Neurobiol; 2016 Sep; 53(7):4893-904. PubMed ID: 26363795 [TBL] [Abstract][Full Text] [Related]
12. Conformational diseases: misfolding mechanisms may pave the way to early therapy. Reiss C; Ehrlich R; Lesnick T; Parvez S; Parvez H Neurotoxicol Teratol; 2002; 24(5):ix-xiv. PubMed ID: 12200201 [No Abstract] [Full Text] [Related]
16. Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders. Donde A; Wong PC; Chen LL Curr Gene Ther; 2017; 17(3):187-193. PubMed ID: 29034834 [TBL] [Abstract][Full Text] [Related]
17. Advances and perspectives in the field of gene transfer technology. Romano G Drug News Perspect; 2006; 19(6):359-68. PubMed ID: 16971973 [TBL] [Abstract][Full Text] [Related]
18. Towards gene therapy of neurodegenerative disease. Federoff HJ; Atkinson M Prog Brain Res; 1998; 117():503-10. PubMed ID: 9932428 [No Abstract] [Full Text] [Related]
19. RNA Therapeutics for Treatment of Cardiovascular Diseases: Promises and Challenges. Lucas T; Dimmeler S Circ Res; 2016 Sep; 119(7):794-7. PubMed ID: 27635083 [No Abstract] [Full Text] [Related]
20. Nanotechnology applications in cancer. Nie S; Xing Y; Kim GJ; Simons JW Annu Rev Biomed Eng; 2007; 9():257-88. PubMed ID: 17439359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]